Overt Hepatic Encephalopathy Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE).
The primary objective of this study is to assess the efficacy of rifaximin SSD plus lactulose versus placebo plus lactulose for the treatment of overt hepatic encephalopathy (OHE). The secondary objectives of this study are to assess the safety of rifaximin SSD in subjects with OHE and to assess the effects of treatment with rifaximin SSD on key secondary endpoints. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04058327 -
A Study of MHE in Patients With Liver Diseases
|
||
| Recruiting |
NCT06374511 -
Prospective Cohort Study of Complications and Outcomes in Cirrhosis
|